Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
JAMA Oncology|September 4, 2020
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical TrialSara M Tolaney, Romualdo Barroso-Sousa, Tanya Keenan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2026
Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)Rana R McKay, Wanling Xie, Archana Ajmera, et al.European Urology|July 8, 2015
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic ProfilingSumanta K Pal, Toni K Choueiri, Kai Wang, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinomaAmin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.Cancer Cell|January 16, 2026
A context-augmented large language model for accurate precision oncology medicine recommendationsHyeji Jun, Yutaro Tanaka, Shreya Johri, et al.British Journal of Cancer|March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.British Journal of Cancer|August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.Cancer|August 9, 2020
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinomaVictor McPherson, Brendan Reardon, Aravind Bhayankara, et al.Nature|July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetRobert T Manguso, Hans W Pope, Margaret D Zimmer, et al.JAMA Oncology|October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical TrialKartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.Pageof 6